Related Experiment Video
Updated: Dec 10, 2025

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
Sydenham Chorea: Putaminal Enlargement.
Zeynep Selen Karalok1, Zeynep Öztürk2, Altan Gunes3
1Department of Pediatric Neurology, 64032Akdeniz University School of Medicine, Antalya, Turkey.
Magnetic resonance imaging (MRI) revealed larger putamen volumes in children with Sydenham chorea, suggesting antibody-mediated inflammation of the putamen as a key factor in this neurological disorder.
Area of Science:
- Neuroimaging
- Neurology
- Pediatrics
Background:
- Sydenham chorea is a neurological disorder affecting children.
- Understanding its pathogenesis is crucial for effective treatment.
- Magnetic resonance imaging (MRI) is a key tool for brain structure analysis.
Purpose of the Study:
- To evaluate MRI's efficacy in detecting brain region changes in Sydenham chorea.
- To investigate the role of basal ganglia structures in Sydenham chorea pathogenesis.
- To compare quantitative MRI volumetric data between patients and controls.
Main Methods:
- Quantitative MRI volumetric analysis using the "volBrain" method.
- Inclusion of 24 Sydenham chorea patients and 35 age/gender-matched controls.
- High-resolution T1-weighted 3D magnetization-prepared rapid acquisition of gradient echo scans.
Main Results:
- No significant differences in globus pallidus, caudate, or thalamic volumes.
- Significantly larger relative mean total, left, and right putamen volumes in Sydenham chorea patients (P = .003, P = .018, P = .001).
- MRI scans were otherwise within normal limits for all subjects.
Conclusions:
- Increased putamen size in Sydenham chorea patients suggests selective neuroanatomic differences.
- Findings support a hypothesis of cross-reactive antibody-mediated inflammation of the putamen.
- MRI provides valuable data for understanding Sydenham chorea's pathophysiology.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease: Overview
Lysosomal Hydrolases
Neural Regulation
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...

